Skip to content
Use caution Drug recall · FDA · Published February 11, 2013

Jubilant Recalls Pantoprazole Tablets Due to Manufacturing Deviations

Jubilant Cadista recalls 12,770 bottles of Pantoprazole Sodium 40mg tablets due to cGMP deviations. Check your lot numbers and expiration dates.

🇺🇸 FDA recall #D-296-2013DrugJubilant Cadista Pharmaceuticals ›
Take action

Contact the company

Recalling firmJubilant Cadista Pharmaceuticals Inc.207 Kiley Dr · Salisbury, MD 21801-2249
✎ GovInfoNow plain-language explainer

What happened, in plain English

Jubilant Cadista Pharmaceuticals Inc. is recalling 12,770 bottles of Pantoprazole Sodium Delayed Release Tablets USP, 40 mg because they were not manufactured in accordance with current Good Manufacturing Practices (cGMP). The affected products are distributed nationwide and include specific lot numbers with expiration dates in May 2014. No remedy or return instructions are currently stated in the record. Read more at govinfonow.com/recall/48345-jubilant-cadista-pharmaceuticals-inc-recalls-pantoprazole-sodium-delayed-release-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/48345-jubilant-cadista-pharmaceuticals-inc-recalls-pantoprazole-sodium-delayed-release-tablets · Updated October 13, 2026 · FDA enforcement record: FDA #D-296-2013

Cite this page

“Jubilant Recalls Pantoprazole Tablets Due to Manufacturing Deviations.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48345-jubilant-cadista-pharmaceuticals-inc-recalls-pantoprazole-sodium-delayed-release-tablets. Based on FDA recall #D-296-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-296-2013%22&limit=1).

Why it’s dangerous

The hazard stems from cGMP deviations, meaning the oral products were not manufactured in accordance with Good Manufacturing Practices. This can lead to inconsistencies in drug strength, purity, or contamination, potentially affecting the medication's safety and efficacy.

Who’s affected

Consumers who purchased Pantoprazole Sodium Delayed Release Tablets USP, 40 mg from nationwide distributors between the time of manufacture and the recall date. Individuals relying on these specific batches for acid reduction or related conditions are most at risk due to potential quality control failures.

How to tell if you have this one

Check your bottle for NDC 59746-284-90. Look for Lot numbers PA22028 or PA22029 with an expiration date of 5/2014. The product is marketed by Jubilant Cadista Pharmaceutical Inc in Salisbury, MD, and manufactured by Jubilant Life Sciences Ltd in India.

  • Brand
    Jubilant Cadista Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your Pantoprazole Sodium bottle has NDC 59746-284-90 and Lot numbers PA22028 or PA22029 with an expiration date of 5/2014.

  2. Contact Manufacturer

    Since no remedy is stated, contact Jubilant Cadista Pharmaceuticals Inc. directly for further instructions on what to do with the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Feb 11, 201312. FDA classified it Class II: Apr 26, 201323. Published in FDA’s Enforcement Report: May 8, 201334. FDA terminated the recall: Dec 23, 201342013
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-296-2013 (February 11, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-296-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA